GSE103122 0 V 1 PUROMYCIN HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE103122 0 V 1 PUROMYCIN HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE103122 0 V 1 PUROMYCIN HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE103122 0 V 1 PUROMYCIN HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE103122 0 V 1 PUROMYCIN HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

Rho GTPase activating protein 23

Gene

PHD finger protein 12

Gene

VRK serine/threonine kinase 3

Gene

solute carrier family 6 member 9

Gene

MFSD2 lysolipid transporter B, sphingolipid

Gene

protein kinase, membrane associated tyrosine/threonine 1

Gene

SRY-box transcription factor 6

Gene

lysine methyltransferase 2B

Gene

lemur tyrosine kinase 2

Gene

myotubularin related protein 14

  • Gene

    Rho GTPase activating protein 23


  • Gene

    PHD finger protein 12


  • Gene

    VRK serine/threonine kinase 3


  • Gene

    solute carrier family 6 member 9


  • Gene

    MFSD2 lysolipid transporter B, sphingolipid


  • Gene

    protein kinase, membrane associated tyrosine/threonine 1


  • Gene

    SRY-box transcription factor 6


  • Gene

    lysine methyltransferase 2B


  • Gene

    lemur tyrosine kinase 2


  • Gene

    myotubularin related protein 14

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.